Purple Biotech Ltd.
Purple Biotech Ltd. (PPBT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PPBT · as of Jun 9, 2026
Key Statistics
Explore Purple Biotech Ltd. Data
ppbt stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 100.0%
Competitors & Peers
ppbt competitorsPPBT
AKTX
CDT
DRMA
FOXO
MSPRStock Performance
Full HistoryAbout Purple Biotech Ltd.
Purple Biotech Ltd. a clinical-stage biotechnology firm based in Rehovot, Israel, is dedicated to pioneering treatments that help cancer patients, particularly in the United States, overcome tumor im…
what is purple biotech ltd. · ppbt stock overview · purple biotech ltd. company profile · who is purple biotech ltd. ceo · ppbt NASDAQ · purple biotech ltd. headquarters · purple biotech ltd. business segments
About Stock Overview & Key Data
Purple Biotech Ltd. (PPBT) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Nov 20, 2015. As of the latest trading session, PPBT stock price is $2.92, with a market capitalization of $403,205. The stock has returned -88.81% over the past 12 months and -55.56% year-to-date.
According to 2 Wall Street analysts, the consensus rating for Purple Biotech Ltd. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Purple Biotech Ltd. reported revenue of — and net income of -$26.4M. For detailed data — including Purple Biotech Ltd. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Purple Biotech Ltd. (PPBT) stock price is $2.92. The stock is traded on NASDAQ under the ticker symbol PPBT. The 52-week range is $2.52 – $29.00.